M&A Deal Summary

Cornerstone Therapeutics Acquires EKR Therapeutics

On June 27, 2012, Cornerstone Therapeutics acquired life science company EKR Therapeutics from NewSpring Capital and LLR Partners for 150M USD

Acquisition Highlights
  • This is Cornerstone Therapeutics’ 1st transaction in the Life Science sector.
  • This is Cornerstone Therapeutics’ largest (disclosed) transaction.
  • This is Cornerstone Therapeutics’ 1st transaction in the United States.
  • This is Cornerstone Therapeutics’ 1st transaction in New Jersey.

M&A Deal Summary

Date 2012-06-27
Target EKR Therapeutics
Sector Life Science
Buyer(s) Cornerstone Therapeutics
Sellers(s) NewSpring Capital
LLR Partners
Deal Type Add-on Acquisition
Deal Value 150M USD

Target

EKR Therapeutics

Bedminster, New Jersey, United States
EKR Therapeutics, Inc. is a specialty pharmaceutical company providing novel products that offer broad therapeutic potential and superior outcomes to acute-care hospitals.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cornerstone Therapeutics

Cary, North Carolina, United States

Category Company
DESCRIPTION

Cornerstone Therapeutics Inc. (CRTX), a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A., headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2012) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 2

SELLER

NewSpring Capital

Radnor, Pennsylvania, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1999
PE ASSETS 3.5B USD
Size Large
Type Sector Agnostic
DESCRIPTION

NewSpring Capital is a private investment firm focused on growth companies in the Mid-Atlantic US. The Firm can provide both growth equity and junior capital to prospective companies. NewSpring's target investment size for both mezzanine and equity financing is $2 to $5 million, although for new ventures, the Firm can commit up to $10 million. Sectors of interest include specialty manufacturing, technology, business services, information technology, life science, healthcare services, and medical devices. NewSpring Capital was formed in 1999 and is based in Radnor, Pennsylvania with an additional office in Short Hills, New Jersey.


DEAL STATS #
Overall 13 of 84
Sector (Life Science) 3 of 6
Type (Add-on Acquisition) 7 of 47
State (New Jersey) 1 of 8
Country (United States) 13 of 83
Year (2012) 1 of 3
Size (of disclosed) 13 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-05-31 Sussex Wire

Easton, Pennsylvania, United States

Sussex Wire, Inc. specializes in the design, manufacturing, and distribution of highly-engineered, specialty metal parts and components utilizing cold-forming technology. Sussex Wire was founded in 1974 and is based in Easton, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-16 Aisthesis

Bethesda, Maryland, United States

Aisthesis provides anesthesiology services to Ambulatory Surgery Centers (ASCs) in the greater Washington D.C. metro area. ASCs perform minor surgeries and medical procedures that would otherwise be performed in hospitals at greater cost and less convenience. Anesthesia's board-certified anesthesiologists perform their services with drugs that produce fewer side effects to patients resulting in shorter recovery times and increased facility utilization for the ASCs.

Buy -
SELLER

LLR Partners

Philadelphia, Pennsylvania, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1999
PE ASSETS 6.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

LLR is a private equity firm that makes growth capital, buyout, and recapitalization investments in mid-sized growth companies with sustainable competitive advantages. LLR looks to invest $30 to $150 million per transaction and will consider both control and minority situations. Target companies generally have at least $10 million in annual sales and are valued up to $250 million. Broad industry sectors of interest include general business services, financial services, healthcare services, education, manufacturing, consumer/retail and information technology/software. LLR will consider investments throughout the US with an emphasis on opportunities located in the Eastern and Mid-Atlantic regions of the US. LLR Partners was formed in 1999 and is based in Philadelphia, Pennsylvania.


DEAL STATS #
Overall 22 of 74
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 13 of 47
State (New Jersey) 6 of 8
Country (United States) 22 of 73
Year (2012) 2 of 3
Size (of disclosed) 9 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-04-01 Acre Security

Las Vegas, Nevada, United States

Acre Security is a manufacturer of electronic security products that are emphasizing the ongoing transition to more open platform systems. Acre Security was founded in 2012 and is based in Las Vegas, Nevada.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-26 Physicians Immediate Care

Rockford, Illinois, United States

Physicians Immediate Care is an operator of urgent care, occupational medicine, physical therapy and employer services such as physicals and drug screening. Physicians Immediate Care was founded in 1987 and is based in Rockford, Illinois.

Buy -